Arkema SA (ARKAY)
104.67
+2.30
(+2.25%)
USD |
OTCM |
May 17, 16:00
Arkema Enterprise Value: 10.19B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 10.19B |
| May 16, 2024 | 10.02B |
| May 15, 2024 | 10.08B |
| May 14, 2024 | 10.40B |
| May 13, 2024 | 10.34B |
| May 10, 2024 | 10.29B |
| May 09, 2024 | 10.29B |
| May 08, 2024 | 10.29B |
| May 07, 2024 | 10.55B |
| May 06, 2024 | 10.29B |
| May 03, 2024 | 10.27B |
| May 02, 2024 | 10.27B |
| May 01, 2024 | 10.27B |
| April 30, 2024 | 10.27B |
| April 29, 2024 | 10.18B |
| April 26, 2024 | 10.09B |
| April 25, 2024 | 9.976B |
| April 24, 2024 | 10.03B |
| April 23, 2024 | 10.09B |
| April 22, 2024 | 10.20B |
| April 19, 2024 | 9.956B |
| April 18, 2024 | 10.11B |
| April 17, 2024 | 10.09B |
| April 16, 2024 | 9.980B |
| April 15, 2024 | 10.09B |
| Date | Value |
|---|---|
| April 12, 2024 | 10.09B |
| April 11, 2024 | 10.09B |
| April 10, 2024 | 10.21B |
| April 09, 2024 | 10.21B |
| April 08, 2024 | 10.40B |
| April 05, 2024 | 10.59B |
| April 04, 2024 | 10.59B |
| April 03, 2024 | 10.60B |
| April 02, 2024 | 10.33B |
| April 01, 2024 | 10.22B |
| March 31, 2024 | 10.25B |
| March 28, 2024 | 10.38B |
| March 27, 2024 | 10.24B |
| March 26, 2024 | 10.24B |
| March 25, 2024 | 10.14B |
| March 22, 2024 | 10.22B |
| March 21, 2024 | 10.22B |
| March 20, 2024 | 10.14B |
| March 19, 2024 | 9.987B |
| March 18, 2024 | 10.01B |
| March 15, 2024 | 10.01B |
| March 14, 2024 | 9.892B |
| March 13, 2024 | 10.10B |
| March 12, 2024 | 10.10B |
| March 11, 2024 | 9.966B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.448B
Minimum
Mar 18 2020
11.82B
Maximum
May 11 2021
9.489B
Average
9.473B
Median
Nov 28 2023
Enterprise Value Benchmarks
| Constellium SE | 4.878B |
| Air Liquide SA | 114.63B |
| Robertet SA | 2.033B |
| Vicat SA | 3.364B |
| Imerys | 3.718B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 85.81M |
| Revenue (Quarterly) | 2.543B |
| Total Expenses (Quarterly) | 2.365B |
| EPS Diluted (Quarterly) | 1.075 |
| Profit Margin (Quarterly) | 3.37% |
| Earnings Yield | 4.85% |
| Operating Earnings Yield | 10.40% |
| Normalized Earnings Yield | 4.845 |